1 citations
,
March 2025 in “Skin Appendage Disorders” Healthcare access for alopecia areata in the USA is unequal among ethnic groups.
July 2026 in “Dermatology and Therapy” In this study, Brazilian dermatologists reported that patients with alopecia areata, particularly those with severe scalp hair loss, often experience an unmet need for advanced therapies that could improve treatment outcomes beyond the limitations of current options.
April 2026 in “Clinical and Experimental Dermatology” The authors concluded that for alopecia areata, addressing psychosocial well-being and social functioning is crucial, as the burden of the condition extends beyond visible hair loss and includes substantial inequities in treatment access.
28 citations
,
February 2021 in “Open Forum Infectious Diseases” This review highlights how social, environmental, and biological factors combine to increase COVID-19 risks in the African American community, emphasizing the need to understand these complex disparities; it reports no new results.
January 2025 in “Bright Sky Publications eBooks” This abstract does not report specific research findings but describes a book titled "Medical Physics and Laser Technology: Advancements and Applications in Modern Healthcare," authored by Zahraa Zuhair Ghafel Saeid and colleagues, which is available for purchase.
December 2025 in “Journal of Inflammation Research” This study highlights ongoing inequities in access and outcomes for inflammatory skin diseases in Latin America and emphasizes the need for regional registries, harmonized clinical guidelines, and policy reforms to improve equitable dermatologic care.
1 citations
,
October 2025 in “Biology of Sex Differences” This study concluded that while sex-related biological factors may influence COVID-19 outcomes, they do not fully explain the differences in mortality between women and men, underscoring the need for a gendered, intersectional approach to understanding health inequities and risk factors.
1 citations
,
July 2025 in “International Journal of Women’s Dermatology” This study found that the "pink tax" persists in topical minoxidil products, with foams marketed to women costing about 20% more than those for men, despite identical ingredients and an overall price increase since 2017.
January 2025 in “SKIN The Journal of Cutaneous Medicine” People with alopecia areata face different healthcare access and experiences based on their race and ethnicity.
January 2024 in “Wiadomości Lekarskie” This analysis of England's National End of Life Care Intelligence Network reports that the initiative improved palliative care using national data, addressing disparities in care especially among the poorest patients and those from non-white ethnicities over 14 years.
This review reported that alopecia prevalence and psychosocial impacts vary significantly among migrant and ethnic minority communities due to diverse genetic, environmental, and cultural factors, highlighting needs for culturally competent care and stigma reduction to address disparities and improve access.
2 citations
,
May 2025 in “BMJ Open” This study identified significant patient frustration with limited access to treatments for alopecia areata in Germany, exacerbated by the absence of health insurance reimbursement for necessary medications.
March 2026 in “Journal of Community Genetics” In this narrative review, the authors found that stigma related to oculocutaneous albinism in Africa is primarily driven by socio-cultural beliefs and structural inequities, affecting individuals' health, education, and psychosocial well-being, with interventions needed to dispel myths and provide specialized healthcare and support.
39 citations
,
April 2011 in “International Journal of Dermatology” This article reviews comprehensive surveys on the prevalence and impact of skin disease in resource-poor countries, but reports no new clinical results; it highlights challenges such as health literacy and service access.
January 2020 in “World Social Psychiatry” This article discusses the inequalities in COVID-19 outcomes affecting vulnerable groups in the UK and calls for more inclusive global pandemic strategies, but presents no new empirical data.
July 2025 in “Skin Appendage Disorders” This study highlights significant psychosocial distress and access barriers faced by South Asian patients, suggesting improved provider education, broader insurance coverage, and enhanced patient assistance programs as necessary steps to achieve equitable healthcare access.
September 2003 in “Journal of the Royal Society of Medicine” The document concludes that while some advocate for a patient voucher system, it may be unequal and current healthcare reforms should be given a chance, and it also recommends various medical books for their comprehensive coverage and advice on specific health issues.
August 2025 in “PLoS ONE” This review explores treatment options for HS in the US and identifies how social disparities impact access to care, but it reports no new clinical findings.
July 2025 in “The Lancet Regional Health - Southeast Asia” This Health Policy report outlines the creation of evidence-based clinical practice guidelines and referral pathways for managing dermatological conditions in Pakistan's primary care setting, aiming to standardize care and improve patient outcomes.
June 2007 in “Journal of The Royal Society for The Promotion of Health” Smoking doubles the risk of blindness, and physical exercise helps dyslexic children read better.
March 2022 in “Women's health issues” This review highlights the urgent need for increased research and policy support for autoimmune and immune-mediated skin diseases, which are on the rise and disproportionately affect women's health in the United States, suggesting a focus on gender and socioenvironmental factors.
January 2024 in “Wiadomości Lekarskie” This study discusses the development of AI in dermatology and cosmetology, noting its use in skin cancer diagnosis and personalized cosmetics, while highlighting uncertainties about whether recent advancements represent significant medical progress or are influenced by marketing strategies.
December 2025 in “International Journal of Innovative Technologies in Social Science” This study systematically reviewed dermatological conditions affecting transgender and gender-diverse individuals, highlighting that testosterone therapy can induce acne in 25–88% of transgender men and alopecia after over two years, while dermatologic care must consider both medical and social complexities.
2 citations
,
June 2024 in “Sociological research and innovation” This study highlighted the complex stigma, misinformation, and coping mechanisms among unmarried women with PCOS in Pakistan, emphasizing the role of family support and accurate information in managing emotional well-being.
3 citations
,
May 2021 in “Dermatologic Clinics” This article reviews global insights on how COVID-19 has transformed the practice of dermatology, but it reports no new clinical results.
January 2024 in “Wiadomości Lekarskie” This presentation explored recent developments in treating alcohol, opioid, and cannabis addiction, highlighting promising pharmacological and behavioral therapies, such as extended-release naltrexone for alcohol use and long-acting buprenorphine for opioids, alongside emerging strategies for cannabis use disorder.
1 citations
,
March 2023 in “Nutrients” This joint consensus statement from several Polish professional associations discusses strategies for improving obesity treatment and enhancing primary care's role in managing obesity, with no new empirical data reported.
January 2024 in “Wiadomości Lekarskie” This study discusses the need for better organization and specialized services in Alzheimer's prevention, focusing on modifiable factors like hearing impairment, vascular risk, and lifestyle habits, and highlights challenges and opportunities from the two-year experience of Brain Health services at Karolinska Institutet in Sweden.
36 citations
,
November 2006 in “Medical Care Research and Review” This review covers the ongoing debate on measuring underinsurance in health coverage and reports no new empirical results, recommending a national effort to standardize underinsurance metrics.
8 citations
,
March 2019 in “Drugs - Real World Outcomes” This study reported that while general patient characteristics and adverse event incidence for eribulin were comparable between a healthcare claims database and post-marketing surveillance, significant differences in some side effects such as neutropenia were observed.